Orthofix International (OFIX) Misses Q4 EPS by 61c ; Offers Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- S&P, Nasdaq drop on tech selloff as concerns about hawkish Fed, AI spending mount
- Chip stocks plunge, but bargain-hunters stem losses in other tech names
- Oil prices steady as investors focus on Hormuz flows after peace talks
- South Korea leveraged ETF crisis sparks global chip selloff
- Trump announces nuclear deal with Iran, lifts Hormuz blockade
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- 'Equal and opposite': BTIG's Krinsky sees sharp reversal ahead for chip stocks
BTIG Reiterates Neutral Rating on Orthofix International (OFIX)
February 25, 2025 1:01 PM ESTBTIG analyst Ryan Zimmerman reiterated a Neutral rating on Orthofix International (NASDAQ: OFIX).
The analyst comments "We maintain our Neutral following 4Q24 results. OFIX reported rev. of $215.7M (7.6% Y/Y, 7.8% xFx) above Cons. at $212.7M while adj. EBITDA of $23.9M beat Street ests. of $22.6M. Growth was driven by Global Orthopedics (18.1% Y/Y xFx) and BGT (8.6% Y/Y).... More
